BioSpace News Archive

BioCapital

Prelude Therapeutics to Present at the H.C. Wainwright BioConnect Virtual Conference

Prelude Therapeutics Inc. will present at the H.C Wainwright BioConnect Virtual Conference, being held on January 10-13, 2022.

January 4, 2022
·
1 min read
Pharm Country

HOOKIPA Pharma to Present at the H.C. Wainwright BioConnect Conference

HOOKIPA Pharma Inc., a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, announced that the Company will present at the virtual H.C. Wainwright BioConnect Conference, January 10 - 13, 2022.

January 4, 2022
·
3 min read
BioCapital

American Diabetes Association and Renalytix Partner to Prioritize Kidney Health in Type 2 Diabetes Population

The American Diabetes Association® and Renalytix announced a joint program to improve overall kidney health in patients with type 2 diabetes in the United States, which is expected to grow from 34 million individuals today to nearly 60 million by 20601.

January 4, 2022
·
7 min read
Pharm Country

Amarin to Present at the 40th Annual J.P. Morgan Healthcare Conference

Amarin Corporation plc is scheduled to present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022, at 8:15 am ET.

January 4, 2022
·
2 min read
BioMidwest

Kraig Biocraft Laboratories Receives Equipment for Onsite Testing and Screening of Transgenic Technology at Prodigy Textiles

Kraig Biocraft Laboratories, Inc. announces it has taken delivery of key lab equipment to Prodigy Textiles, the Company’s Vietnam based subsidiary, to support onsite testing and screening of spider silk transgenic technologies.

January 4, 2022
·
3 min read
Business

Genocea Biosciences Provides Corporate Update

Genocea Biosciences, Inc. has entered into an R&D collaboration and option agreement with Janssen Biotech, Inc., to explore the immunogenicity of neoantigens and the role and impact of Inhibigens™ in the context of vaccine therapies for cancer.

January 4, 2022
·
6 min read
BioMidwest

Talaris Therapeutics to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference

Talaris Therapeutics, Inc. announced that Scott Requadt, Chief Executive Officer of Talaris, will present at the H.C. Wainwright BioConnect 2022 Virtual Conference being held January 10-13, 2022.

January 4, 2022
·
1 min read
New Survey From Bausch + Lomb And Glaucoma Research Foundation Reveals Emotional and Social Impact of Hyperemia on Glaucoma Patients

Bausch + Lomb and Glaucoma Research Foundation, released, during Glaucoma Awareness Month, new key findings from a survey of glaucoma patients that was designed to gain a greater understanding of the impact that hyperemia can have in the treatment and lives of people living with glaucoma.

January 4, 2022
·
8 min read
Bio NC

Milestone Pharmaceuticals to Present at the H.C. Wainwright BIOCONNECT Virtual Conference

Milestone Pharmaceuticals Inc. announced that Joseph Oliveto, President and Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright BIOCONNECT Virtual Conference being held on January 10-13, 2022.

January 4, 2022
·
1 min read
Business

Chemomab Therapeutics Names Jack Lawler Vice President of Global Clinical Development Operations

Chemomab Therapeutics Ltd today named Jack Lawler Vice President of Global Clinical Development Operations.

January 4, 2022
·
5 min read